Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study
- 30 April 2007
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 56 (4) , 491-496
- https://doi.org/10.1016/j.metabol.2006.11.007
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adiponectin: Protection of the endotheliumCurrent Diabetes Reports, 2005
- Low Plasma Adiponectin Levels Predict Progression of Coronary Artery CalcificationCirculation, 2005
- Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?Heart, 2004
- Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose TolerancePublished by American Medical Association (AMA) ,2004
- Insulin Sensitivity, Insulinemia, and Coronary Artery DiseaseDiabetes Care, 2004
- Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known DiabetesDiabetes Care, 2003
- Hypoadiponectinemia Is Closely Linked to Endothelial Dysfunction in ManJournal of Clinical Endocrinology & Metabolism, 2003
- Sex Differences in the Association Between Proinsulin and Intact Insulin With Coronary Heart Disease in Nondiabetic Older AdultsCirculation, 2002
- High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen StudyDiabetes Care, 1998
- Significance of High HbA1 Levels in Normal Glucose ToleranceDiabetes Care, 1988